Skip to main content
. 2022 Nov 21;12(11):e062570. doi: 10.1136/bmjopen-2022-062570

Table 2.

Mean symptom severity as rated by the PANSS and BACS performance for the whole sample for each study visit

Baseline 2-week follow-up 6-week follow-up Baseline vs 2 weeks 2 weeks vs 6 weeks Baseline vs 6 weeks
Variable N M SD N M SD N M SD Wilcoxon signed-rank Wilcoxon signed-rank Wilcoxon signed-rank
PANSS positive 45 11.93 4.77 36 9.17 5.36 38 7.26 5.13 Z=2.76, p=0.006* Z=2.67, p=0.008* Z=4.50, p<0.001*
PANSS negative 45 10.36 6.87 36 10.31 7.15 38 9.58 7.78 Z=0.78, p=0.435 Z=0.62, p=0.535 Z=1.17, p=0.242
PANSS general 45 19.40 8.57 36 16.64 10.60 38 15.74 10.11 Z=3.21, p=0.001* Z=2.48, p=0.013* Z=0.64, p=0.524
PANSS total 45 41.69 16.11 36 36.11 20.03 38 32.58 20.04 Z=3.10, p=0.002* Z=1.46, p=0.144 Z=3.35, p<0.001*
BACS verbal memory 41 37.83 14.02 32 41.16 13.50 36 44.56 15.02 Z=−3.14, p=0.002* Z=−3.15, p=0.002* Z=−3.88, p<0.001*
BACS digit sequencing 38 18.03 4.06 32 17.84 4.33 34 17.85 4.69 Z=−0.78, p=0.433 Z=−0.40, p=0.688 Z=0.40, p=0.687
BACS verbal fluency 42 28.60 7.85 31 31.87 9.47 35 30.20 8.38 Z=−1.96, p=0.050* Z=0.83, p=0.405 Z=−1.62, p=0.105
BACS token motor 39 65.36 10.83 32 65.56 17.81 34 61.38 20.94 Z=−1.30, p=0.193 Z=−0.55, p=0.583 Z=−0.24, p=0.812
BACS symbol coding 39 40.15 13.13 32 45.69 12.56 32 47.25 11.96 Z=−2.25, p=0.025* Z=−1.07, p=0.284 Z=−3.29, p=0.001*
BACS ToL 37 14.84 4.48 29 17.38 3.29 32 16.28 4.13 Z=−3.24, p=0.001* Z=1.45, p=0.148 Z=−2.42, p=0.016*
BACS t-score 33 26.67 11.98 28 34.14 11.68 30 30.87 14.95 Z=−3.79, p<0.001* Z=−0.29, p=0.769 Z=−3.66, p<0.001*
BACS z-score 33 −2.34 1.19 28 −1.59 1.17 30 −1.91 1.50 Z=−3.85, p<0.001* Z=−0.23, p=0.820 Z=−3.67, p<0.001*

*Significant at p=0.05 level.

BACS, Brief Assessment of Cognition in Schizophrenia; PANSS, Positive and Negative Symptom Scale; ToL, Tower of London.